Daonil 5mg Tablet

Daonil 5mg Tablet contains glibenclamide as its active ingredient, which belongs to the class of sulfonylurea antidiabetic agents. It is primarily used to manage type 2 diabetes mellitus by helping to lower blood sugar levels.

Uses:

Daonil 5mg Tablet is prescribed for the following purposes:

1. Type 2 diabetes mellitus: It helps control blood glucose levels in patients with type 2 diabetes by stimulating the release of insulin from the pancreas and increasing the sensitivity of peripheral tissues to insulin.
2. Adjunct to diet and exercise: Daonil 5mg Tablet is often used as an adjunct to diet and exercise when lifestyle modifications alone are insufficient to achieve glycemic control.

Side Effects:

While Daonil 5mg Tablet is generally effective, some individuals may experience side effects, including:

1. Hypoglycemia: This is the most common side effect of glibenclamide and can manifest as sweating, shaking, dizziness, confusion, or fainting.
2. Gastrointestinal disturbances: These may include nausea, vomiting, diarrhea, or abdominal discomfort.
3. Skin reactions: Rarely, some people may experience skin rashes, itching, or photosensitivity reactions.
4. Weight gain: Glibenclamide can contribute to weight gain in some individuals.
5. Liver toxicity: Prolonged use of glibenclamide may lead to liver dysfunction in rare cases.

Precautions:

1. Regular monitoring: Patients taking Daonil 5mg Tablet should undergo regular monitoring of blood glucose levels to assess the effectiveness of treatment and detect hypoglycemia.
2. Hypoglycemia risk: Individuals at higher risk of hypoglycemia, such as the elderly, those with renal impairment, or those with irregular eating habits, should be monitored closely while taking glibenclamide.
3. Drug interactions: Glibenclamide may interact with certain medications, including other antidiabetic agents, NSAIDs, and certain antibiotics. It’s essential to inform your doctor about all medications you are taking before starting Daonil therapy.
4. Pregnancy and breastfeeding: Daonil 5mg Tablet is not recommended during pregnancy or breastfeeding, as it may cross the placenta and pass into breast milk, potentially affecting the baby’s blood sugar levels.
5. Alcohol consumption: Limit alcohol intake while taking glibenclamide, as it may increase the risk of hypoglycemia.

When Not to Use:

Daonil 5mg Tablet should not be used in the following situations:

1. Type 1 diabetes mellitus: It is not effective in the treatment of type 1 diabetes, which requires insulin therapy.
2. Severe renal or hepatic impairment: Glibenclamide is contraindicated in patients with severe renal or hepatic dysfunction due to the increased risk of hypoglycemia and other adverse effects.

FAQ:

1. Can Daonil 5mg Tablet be used alone for diabetes management? Daonil 5mg Tablet is often used in combination with other antidiabetic medications or insulin therapy for optimal glycemic control. Your doctor will determine the most appropriate treatment regimen based on your individual needs.
2. How quickly does Daonil work to lower blood sugar levels? The onset of action of Daonil 5mg Tablet varies from person to person but generally occurs within 1 to 2 hours after ingestion, with peak effects observed within 3 to 4 hours.
3. What should I do if I experience symptoms of hypoglycemia while taking Daonil? If you experience symptoms of hypoglycemia such as sweating, shaking, or confusion, consume a fast-acting carbohydrate such as glucose tablets or fruit juice to raise your blood sugar levels. If symptoms persist or worsen, seek medical attention promptly.
4. Is it safe to drive or operate machinery while taking Daonil 5mg Tablet? Some individuals may experience dizziness or drowsiness as side effects of glibenclamide. If you experience these symptoms, avoid driving or operating machinery until you know how the medication affects you.
5. Can I drink grapefruit juice while taking Daonil? It’s best to avoid consuming grapefruit juice while taking Daonil 5mg Tablet, as it may interfere with the metabolism of glibenclamide and increase the risk of hypoglycemia.